Literature DB >> 851302

Pericarditis and perimyocarditis associated with active Mycoplasma pneumoniae infection.

M J Sands, J E Satz, W E Turner, L A Soloff.   

Abstract

In 13 patients an association existed from 1970-73 between Mycoplasma pneumoniae infection and acute pericarditis (in eight) or perimyocarditis (in five). In 12 patients the association was moderately probable, with a fourfold rise in complement-fixing antibody titers between acute and convalescent phase sera being noted. In the last patient, a lesser-order association was found using only convalsecent phase serum. The presence of influenza, herpes simplex, Coxsackie B, or adenovirus was excluded by serologic testing. Acute illness was variable, with four patients developing heart failure. Long-term evaluation (mean, 47 months) found eight patients asymptomatic and three symptomatic. Two patients died. Residual effects of the Mycoplasma infection seemed at least partially responsible in one compromised patient and in one who died. Mycoplasma infection should be considered in the presence of acute cardiovascular decompensation, especially when preceded by upper respiratory infection, and added to the possible causes of idiopathic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 851302     DOI: 10.7326/0003-4819-86-5-544

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  13 in total

1.  Severe Mycoplasma disease--rare or underdiagnosed?

Authors:  G H Cassell
Journal:  West J Med       Date:  1995-02

2.  Mycoplasma pneumoniae pneumonia. Experience at a referral center.

Authors:  D H Linz; S W Tolle; D L Elliot
Journal:  West J Med       Date:  1984-06

3.  Mycoplasma pneumoniae endocarditis.

Authors:  K Popat; D Barnardo; M Webb-Peploe
Journal:  Br Heart J       Date:  1980-07

4.  [Familial Mycoplasma pneumonia. The varied picture of pulmonary and extrapulmonary manifestations].

Authors:  G Lohmöller; C Mrowka; C Rosendahl; B Weigold
Journal:  Klin Wochenschr       Date:  1987-09-01

5.  Mycoplasma pneumoniae protein involved in the antibody response in human infection.

Authors:  S Räisänen; J I Suni; A Vaheri
Journal:  J Clin Pathol       Date:  1984-10       Impact factor: 3.411

6.  Levamisole and surgery in bronchial carcinoma patients: increase in deaths from cardiorespiratory failure.

Authors:  H M Anthony; A J Mearns; M K Mason; D G Scott; K Moghissi; P B Deverall; Z J Rozycki; D A Watson
Journal:  Thorax       Date:  1979-02       Impact factor: 9.139

7.  Mycoplasma pneumonia with fulminant evolution into diffuse interstitial fibrosis.

Authors:  J M Kaufman; C A Cuvelier; M Van der Straeten
Journal:  Thorax       Date:  1980-02       Impact factor: 9.139

Review 8.  Mycoplasmas in diseases of humans.

Authors:  J E Embree; J A Embil
Journal:  Can Med Assoc J       Date:  1980-07-19       Impact factor: 8.262

9.  Isolation of Mycoplasma bovis from a patient with systemic illness.

Authors:  S Madoff; B Q Pixley; R A DelGiudice; R C Moellering
Journal:  J Clin Microbiol       Date:  1979-06       Impact factor: 5.948

10.  Roles of innate and adaptive immunity in respiratory mycoplasmosis.

Authors:  S C Cartner; J R Lindsey; J Gibbs-Erwin; G H Cassell; J W Simecka
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.